“Our device is a next-generation technology, consisting of a biomarker currently not found in any other respiratory device, redefining COPD treatment. It works on the principle of tracking lung resonance using digital signal processing and machine learning algorithms to continuously monitor and predict attacks. It will enable providers and patients to intervene earlier and prevent unnecessary ER and hospital visits.”
–Maria Artunduaga